1) O-phthaloylhydroxamic acid (OPHA)
邻苯二甲酰异羟肟酸
2) P-phthailichydorxamic acid
对苯二甲酰异羟肟酸
3) benzohydroxamatic acid
苯甲酰异羟肟酸
1.
On the basis of synthesis of bis(benzohydroxamato)oxovanadyl(Ⅳ) compound containing benzohydroxamatic acid, the titled complex has been synthesized and characterized by elemental analyses and IR, 1HNMR, 13C NMR, 51V NMR and UV-vis spectroscopies.
以苯甲酰异羟肟酸为配体 ,首先合成四价氧钒化合物 ,以此为基础合成了标题化合物 ,并用元素分析 ,红外光谱 ,1 HNMR ,1 3 CNMR ,51 VNMR ,电子吸收光谱等 ,分别对它进行了表征 ,其结构用单晶X射线衍射法测定 ,晶体属三斜晶系 ,P1空间群 ,所得晶体学参数为a =1 1119(3)nm ,b =1 1735 (3)nm ,c=0 86 6 0 (2 )nm ,α =96 84(1)° ,β=10 6 93(1)° ,γ =88 97(1)°,V =1 0 731(2 )nm3 ,Dc=1 415g cm3 ,Z =2 ,F(0 0 0 ) =478,μ =5 0 6cm- 1 。
4) phthalcoyl hydroxamic acid
苯二酰异羟肟酸
1.
The ligands of phthalcoyl, isophthalcoyl and terephthalcoyl hydroxamic acids and their complexes with Cu(Ⅱ), Co(Ⅱ), Ni(Ⅱ) and Zn(Ⅱ) have been synthesized and determined by IR spectra.
报道了邻、间和对苯二酰异羟肟酸配体及其Cu( ),Co( ),Ni( )和Zn( )的金属配合物的合成,利用红外光谱进行了结构推测,结果表明,羰基和羟基的氧原子是可能的配位原子。
5) Di-n-butyl-di-(4-chlorobenzohy-droxamato)Tin(IV) chloride(DBDCT)
二-(4-氯苯甲酰异羟肟酸)二正丁基合锡
6) suberoylanilide hydroxamic acid
辛二酰苯胺异羟肟酸
1.
The aim of the study was to explore the synergistic effect of the proteasome inhibitor bortezomib(bor) and the histone deacetylase inhibitor suberoylanilide hydroxamic acid(SAHA) on apoptosis of T lymphoma cell lines Jurkat and Hut78,and on the formation of aggresome.
本研究探讨蛋白酶体抑制剂硼替唑米(bortezomib)和组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸(suberoylanilide hydroxamic acid,SAHA)对T淋巴瘤细胞株Jurkat和Hut78的协同诱导凋亡作用,以及两药联合对蛋白聚集体形成的影响。
补充资料：苯甲羟肟酸
分子式：C7H7NO2
分子量：137.14
CAS号：495-18-1
性质：熔点126-130°C。水溶性22 g/L (6°C)。
分子量：137.14
CAS号：495-18-1
性质：熔点126-130°C。水溶性22 g/L (6°C)。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条